Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Unity Biotechnology Inc.

    NASDAQ: UBX · Real-Time Price · USD
    0.77
    -0.02 (-1.91%)
    At close: Jun 27, 2025, 3:59 PM
    0.80
    3.64%
    After-hours: Jun 27, 2025, 05:58 PM EDT

    Unity Biotechnology Statistics

    Share Statistics

    Unity Biotechnology has 17.21M shares outstanding. The number of shares has increased by 0.46% in one year.

    Shares Outstanding

    n/a
    		 17.21M

    Shares Change (YoY)

    n/a
    		 0.46%

    Shares Change (QoQ)

    n/a
    		 0.1%

    Owned by Institutions (%)

    n/a
    		 1.66%

    Shares Floating

    n/a
    		 15.68M

    Failed to Deliver (FTD) Shares

    n/a
    		 4,538

    FTD / Avg. Volume

    n/a
    		 1.63%

    Short Selling Information

    The latest short interest is 572.5K, so 3.33% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 572.5K

    Short % of Shares Out

    n/a
    		 3.33%

    Short % of Float

    n/a
    		 3.39%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.63 and the forward PE ratio is -0.97. Unity Biotechnology's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.63

    Forward PE

    n/a
    		 -0.97

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.8

    PB Ratio

    n/a
    		 2.53

    P/FCF Ratio

    n/a
    		 -0.79

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Unity Biotechnology.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.62, with a Debt / Equity ratio of 3.62.

    Current Ratio

    n/a
    		 2.62

    Quick Ratio

    n/a
    		 2.62

    Debt / Equity

    n/a
    		 3.62

    Debt / EBITDA

    n/a
    		 -0.94

    Debt / FCF

    n/a
    		 -1.13

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,624,375

    Employee Count

    n/a
    		 16

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -42.96% in the last 52 weeks. The beta is 1.06, so Unity Biotechnology's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.06

    52-Week Price Change

    n/a
    		 -42.96%

    50-Day Moving Average

    n/a
    		 0.84

    200-Day Moving Average

    n/a
    		 1.31

    Relative Strength Index (RSI)

    n/a
    		 46.57

    Average Volume (20 Days)

    n/a
    		 277,854

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -31.17M

    Net Income

    n/a
    		 -25.99M

    EBITDA

    n/a
    		 -25.12M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -1.54
    Full Income Statement

    Balance Sheet

    The company has 7.58M in cash and 23.54M in debt, giving a net cash position of -15.96M.

    Cash & Cash Equivalents

    n/a
    		 7.58M

    Total Debt

    n/a
    		 23.54M

    Net Cash

    n/a
    		 -15.96M

    Retained Earnings

    n/a
    		 -510.34M

    Total Assets

    n/a
    		 30.35M

    Working Capital

    n/a
    		 8.58M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -20.86M and capital expenditures 0, giving a free cash flow of -20.86M.

    Operating Cash Flow

    n/a
    		 -20.86M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -20.86M

    FCF Per Share

    n/a
    		 -1.24
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    UBX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for UBX is $3, which is 289.6% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $3

    Price Target Difference

    n/a
    		 289.6%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Oct 20, 2022. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Oct 20, 2022

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -26.82

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist